# Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics
Canonical URL: https://biopharmsignal.com/news/RPTX/repare-therapeutics-announces-out-licensing-of-its-discovery-platforms-to-dcx-biotherapeutics
Ticker: RPTX
Company: Repare Therapeutics
Source: Repare Therapeutics
Published: 2025-05-01 11:00 EST
Original Source URL: https://ir.reparerx.com
## Summary

CAMBRIDGE, Mass. & MONTREAL --(BUSINESS WIRE)--May 1, 2025-- Repare Therapeutics Inc. (“Repare”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that it has out-licensed its discovery platforms, including certain platform and program intellectual property, to

## Article Body
CAMBRIDGE, Mass. & MONTREAL --(BUSINESS WIRE)--May 1, 2025-- Repare Therapeutics Inc. (“Repare”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that it has out-licensed its discovery platforms, including certain platform and program intellectual property, to
## Recent Company News
- 2026-01-16 21:58 EST — [Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.](https://biopharmsignal.com/news/RPTX/repare-shareholders-approve-acquisition-by-xenotherapeutics-inc) — Source: Repare Therapeutics
- 2025-12-24 12:00 EST — [Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration](https://biopharmsignal.com/news/RPTX/repare-therapeutics-announces-acquisition-of-pol-atpase-inhibitor-rp-3467-by-gilead-sciences-for-up-to-30-million-in-total-consideration) — Source: Repare Therapeutics
- 2025-11-20 22:25 EST — [Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc.](https://biopharmsignal.com/news/RPTX/repare-therapeutics-enters-into-support-and-voting-agreements-with-significant-shareholders-for-proposed-transaction-with-xenotherapeutics-inc) — Source: Repare Therapeutics
- 2025-11-14 21:44 EST — [Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.](https://biopharmsignal.com/news/RPTX/repare-therapeutics-enters-into-definitive-agreement-to-be-acquired-by-xenotherapeutics-inc) — Source: Repare Therapeutics
- 2025-10-13 20:05 EST — [Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics](https://biopharmsignal.com/news/RPTX/repare-therapeutics-to-present-initial-data-from-phase-1-lions-clinical-trial-at-37th-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics) — Source: Repare Therapeutics
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)